Quality is intricate part of our business
1100 quality experts
Consecutive 4 successful US FDA audits
With an objective to make affordable and accessible medication available, each MSN member has worked with high commitment and passion, helping us reach great heights. In a short span of 17 years, we recorded hundred percent growth over multiple years. We grew from zero in 2004 to USD 500 million in 2019. Apart from global accreditations and international regulatory standards, MSN has to its credit:
Excellence and consistency – our priorities every step of the way.